Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
PreScission Protease for Keap1 Condensate Workflows
2026-08-12
PreScission Protease combines sequence-defined HRV 3C protease activity with a low-temperature workflow suited to fragile fusion proteins and condensate assays. This guide shows how to remove affinity tags from dKeap1 constructs, preserve assay-relevant protein behavior, and troubleshoot cleavage without confusing tag effects with genuine phase-separation biology.
-
Phytol Assays: Formulation, Isomers, and Signal Logic
2026-08-12
Phytol is more than an RXR ligand: its isomeric composition, hydrophobic formulation, metabolism, and GABAergic activity can all shape assay interpretation. This article presents a formulation-first framework that connects phytol biology with a useful, carefully bounded insight from polymer self-assembly research.
-
DAPI Workflows for PAD4 and NET Imaging
2026-08-11
Build reliable DAPI workflows for nuclear visualization, membrane-integrity screening, and NET-associated tumor research. This practical guide connects DAPI imaging and flow cytometry with the PAD4–H3cit–NETs findings reported in a tumor-inhibition study.
-
METTL16-SENP3-LTF Axis in HCC Ferroptosis
2026-08-11
Wang et al. identify a METTL16-SENP3-LTF signaling axis that connects m6A-dependent RNA regulation with iron sequestration and ferroptosis resistance in hepatocellular carcinoma. The work combines cellular, organoid, mouse-model, biochemical, and human-sample evidence, supporting this pathway as a mechanistically grounded target for ferroptosis sensitization.
-
Streptavidin-Cy3 for Biohybrid Microrobot Assays
2026-08-10
Streptavidin-Cy3 converts biotinylated antibodies, nucleic acid probes, and proteins into bright spatial readouts for tracking biohybrid microrobots in complex tumor models. This workflow pairs a high-affinity biotin-binding reagent with Cy3-compatible imaging while preserving a clear distinction between localization assays and the reference study’s therapeutic photodynamic-treatment experiments.
-
Biohybrid Microrobots for Barrier Penetration
2026-08-09
Gong and colleagues developed magnetically guided biohybrid microrobots by combining the deformable microalga Euglena gracilis with magnetic architectures. The platform couples externally controlled propulsion and deformation with autonomous tumor-tropic behavior, while retaining chlorophyll-dependent photodynamic activity and the biological functions of the living carrier.
-
Basic Protein Native PAGE Kit (K4142)
2026-08-08
The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit supports native protein gel electrophoresis for proteins with pI ≤ 7.0. Its acidic-protein workflow uses non-denaturing conditions, gel sieving, and charge-dependent mobility to help preserve structure and biological activity during separation.
-
Phosphotungstic Acid Negative Stain Solution: EM
2026-08-07
Turn purified spikes, virions, bacteria, and macromolecular assemblies into high-contrast electron microscopy targets with a ready-to-use 2% negative stain. This workflow connects morphology checks to coronavirus entry research while clearly separating structural evidence from glycan-binding and antiviral conclusions.
-
Transdermal PTEN mRNA Delivery with HA-LNPs for Melanoma The
2026-08-07
This study introduces a hyaluronate-conjugated lipid nanoparticle (HA-LNP) system for non-invasive, transdermal delivery of PTEN mRNA, targeting immune-evasive melanoma. By replacing PEG with HA-DMG, the platform achieves efficient tumor suppressor gene expression, immune activation, and tumor inhibition, demonstrating a promising advance in localized mRNA-based cancer immunotherapy.
-
NADH in Metabolic and Mitochondrial Research: Applied Workfl
2026-08-06
Leverage reduced nicotinamide adenine dinucleotide (NADH) for robust interrogation of cellular energy metabolism, mitochondrial function, and redox-driven disease models. This article bridges cutting-edge protocol design, troubleshooting, and comparative insight to maximize reproducibility and innovation in NADH-based research.
-
Ibotenic acid (SKU B6246): Reliable NMDA Receptor Agonist fo
2026-08-06
This scenario-driven guide explores how Ibotenic acid (SKU B6246) from APExBIO addresses real laboratory challenges in neurodegeneration research. Drawing on recent in vivo evidence, the article demonstrates best practices, data interpretation strategies, and product selection tips that drive reproducibility and workflow efficiency for cell viability, cytotoxicity, and neuronal injury assays.
-
Risedronate Sodium: Expanding Horizons in Bone and Cancer Re
2026-08-05
Explore the advanced roles of Risedronate Sodium as a FPP synthase inhibitor in both bone metabolism and cancer research. This article delivers a deep, evidence-based analysis of its molecular action, translational applications, and protocol guidance for next-generation assays.
-
AO/PI Staining Solution: Redefining Cell Viability for Trans
2026-08-05
Explore how AO/PI Staining Solution, a dual fluorescent DNA dye reagent from APExBIO, is transforming the rigor and reproducibility of live/dead cell discrimination in translational research. This thought-leadership piece bridges mechanistic clarity, workflow strategy, and clinical relevance, with actionable guidance for optimizing fluorescence-based viability assays—especially in disease models such as diabetic nephropathy, where precise cell quantification underpins impactful discovery.
-
Canagliflozin as an SGLT2 Inhibitor: Advanced Diabetes Resea
2026-08-04
Canagliflozin is redefining diabetes and kidney research by combining potent SGLT2 inhibition with mitochondrial remodeling capabilities. Discover optimized workflows, troubleshooting tips, and actionable protocol parameters that leverage this dual-action compound for maximum assay sensitivity and translational relevance.
-
Diclofenac as a Non-Selective COX Inhibitor in Organoid Rese
2026-08-04
Diclofenac’s high purity and solubility make it an ideal tool for advanced cyclooxygenase inhibition assays in complex human iPSC-derived intestinal organoid models. This article details experimental setup, protocol parameters, troubleshooting, and the translation of new pharmacokinetic approaches for inflammation and pain signaling pathway studies.